7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-09-30 2015-06-30 2015-03-31 2014-06-30 2014-03-31 
      
    		                                            
      operating activities
    		                                            
      net income
    		19,137,000 -980,000 7,047,000 5,113,000 15,155,000 5,734,000 -1,864,000 -28,293,000 -29,618,000 -8,402,000 -8,091,000 -3,844,000 -8,723,000 -9,532,000 -14,461,000 -10,528,000 -14,129,000 -9,038,000 -41,868,000 -8,044,000 -4,124,000 -11,025,000 -11,716,000 -7,458,000 -730,000 -2,494,000 -1,917,000 -3,105,000 -4,469,000 -6,248,000 -9,177,000 -8,439,000 -7,049,000 -7,298,000 -8,217,000 -4,403,000 -5,637,000 -11,243,000 -10,075,000 -8,945,000 -9,136,000 -7,610,000 -6,655,000 -6,674,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                                            
      depreciation and amortization
    		5,266,000 5,489,000 5,362,000 6,253,000 5,878,000 5,738,000 5,590,000 6,336,000 7,323,000 6,859,000 6,670,000 6,556,000 6,324,000 6,492,000 6,556,000 6,404,000 6,139,000 4,500,000 2,550,000 2,025,000 1,990,000 1,957,000 1,972,000 1,281,000 967,000 924,000 945,000 970,000 981,000 989,000 980,000 1,002,000 993,000 944,000 902,000 909,000 899,000 941,000 762,000 646,000 644,000 352,000 277,000 264,000 
      loss on disposal of property, plant and equipment
    		0   71,000 63,000 38,000 30,000  0 15,000 121,000                                  
      stock-based compensation
    		10,757,000 10,985,000 10,958,000 9,629,000 8,747,000 9,854,000 8,019,000 7,512,000 7,263,000 10,381,000 7,985,000 6,867,000 7,283,000 5,939,000 6,645,000 6,732,000 7,868,000 4,064,000 3,855,000 3,641,000 3,089,000 3,360,000 2,905,000 2,842,000 2,640,000 2,566,000 1,759,000 1,533,000 1,519,000 1,731,000 1,175,000 1,792,000 1,611,000 1,642,000 1,572,000 1,633,000 1,572,000 1,677,000 1,496,000 1,474,000 1,489,000 1,223,000 875,000 492,000 
      deferred income taxes
    		-87,000 59,000 15,000 -243,000 -13,000 143,000 -120,000 -2,996,000 -968,000                                    
      noncash lease expense
    		689,000 696,000 904,000 1,327,000 1,341,000 1,148,000 1,139,000 1,028,000 1,153,000 1,074,000 903,000 833,000 849,000 1,051,000 587,000 66,000 681,000 627,000 258,000 250,000 245,000 237,000 232,000                      
      revaluation of acquisition-related contingent consideration
    		166,000 -925,000 -1,954,000 925,000 379,000 858,000 5,000 117,000 -5,156,000 141,000 -485,000 234,000 -32,000 -79,000 31,000 507,000 56,000 55,000 192,000 1,174,000 472,000 344,000 -484,000                      
      effect of foreign currency on operations
    		1,205,000 -3,465,000 -1,585,000 2,895,000 -1,681,000 259,000 637,000 -1,753,000 824,000 57,000 -224,000 -1,041,000 847,000 585,000 131,000 -390,000 -265,000 1,784,000 82,000 -17,000                         
      amortization of discount on short-term investments
    		                                            
      impairment loss
    		0   2,754,000 185,000 0 429,000 32,039,000 34,900,000 0 1,410,000                                  
      non-cash loss on deconsolidation of subsidiary
    		                                            
      changes in operating assets and liabilities:
    		                                            
      accounts receivable
    		425,000 2,770,000 -7,053,000 1,991,000 1,690,000 -3,627,000 -6,459,000 -763,000 2,861,000 3,091,000 -1,302,000 -139,000 -1,420,000 639,000 -3,575,000 -2,286,000 428,000 -2,965,000 -3,748,000 -787,000 -2,281,000 3,785,000 238,000 4,284,000 -3,987,000 -3,011,000 -3,447,000 -906,000 744,000 192,000 -482,000 -1,081,000 -608,000 -1,902,000 -369,000 -2,444,000 -2,925,000 -159,000 207,000   466,000   
      supplies and inventory
    		221,000 -565,000 -2,298,000 -1,696,000 -909,000 -963,000 -2,303,000 -58,000 -4,418,000 1,727,000 1,055,000 -170,000 813,000 -2,453,000 -1,201,000                              
      prepaid expenses and other current assets
    		-956,000 -2,532,000 -2,928,000 -1,445,000 2,332,000 555,000 -2,738,000 1,120,000 952,000 534,000 -3,064,000 1,415,000 1,805,000 309,000 -2,139,000 -1,411,000 -617,000 -1,420,000 132,000 -47,000 -259,000 154,000 -818,000 -31,000 377,000 -181,000 -11,000               38,000   
      other assets
    		1,720,000 -629,000 -760,000 134,000 -497,000 -1,472,000 259,000 -172,000 462,000 -557,000 -491,000 -3,209,000 -124,000 -167,000 451,000 -569,000 383,000 28,000 -58,000 -97,000 -32,000 31,000 135,000 -209,000 -167,000 -12,000 37,000 -249,000 -239,000 -132,000 -140,000 -148,000   7,000 69,000 -31,000        
      operating lease liabilities
    		-495,000 -609,000 -577,000  -1,483,000 -1,393,000 -1,053,000  -1,134,000 -1,141,000 -950,000  -890,000 -1,083,000 -597,000                              
      accounts payable
    		-3,660,000 -4,007,000 7,120,000 -1,355,000 -1,244,000 -162,000 -1,544,000 -319,000 -607,000 -1,220,000 2,012,000 477,000 1,048,000 -413,000 -960,000 1,283,000 1,114,000 827,000 1,931,000 1,245,000 -656,000 -5,328,000 5,450,000 -2,646,000 759,000 20,000 1,726,000 1,068,000 -724,000 -1,402,000 -510,000 837,000 625,000 -262,000 528,000 -1,054,000 418,000 -1,106,000 301,000    1,332,000 2,045,000 
      accrued liabilities and deferred revenue
    		9,125,000 6,798,000 -8,889,000 -351,000 20,000 12,865,000 -8,993,000 2,724,000 334,000 3,987,000 -7,721,000 2,106,000 -728,000 -4,908,000 -390,000 11,096,000 -1,441,000 4,532,000 238,000                          
      net cash from operating activities
    		44,757,000 33,605,000 5,362,000 24,524,000 29,963,000 29,575,000 -8,966,000 15,552,000 14,171,000 16,671,000 -2,172,000 9,744,000 7,026,000 -363,000 -8,872,000 8,446,000 -1,393,000 1,887,000 -40,561,000 2,261,000 1,752,000 -8,423,000 -5,301,000 1,790,000 -1,556,000 -2,455,000 -1,011,000 -1,226,000 -1,783,000 -3,099,000 -7,413,000 -5,816,000 -5,103,000 -4,910,000 -8,086,000 -4,232,000 -7,438,000        
      capex
    		-2,469,000 -1,758,000 -842,000 -4,141,000 -3,581,000 -2,633,000 -380,000 -2,497,000 -2,488,000 -5,183,000 631,000 -1,872,000 -1,768,000 -2,783,000 -2,111,000 -841,000 -2,800,000 -865,000 -839,000 -888,000 -635,000 -649,000 -552,000 -1,100,000 -232,000 -659,000 -670,000 -204,000 -659,000 -534,000 -171,000 -446,000 -727,000 -113,000 -615,000 -450,000 -173,000        
      free cash flows
    		42,288,000 31,847,000 4,520,000 20,383,000 26,382,000 26,942,000 -9,346,000 13,055,000 11,683,000 11,488,000 -1,541,000 7,872,000 5,258,000 -3,146,000 -10,983,000 7,605,000 -4,193,000 1,022,000 -41,400,000 1,373,000 1,117,000 -9,072,000 -5,853,000 690,000 -1,788,000 -3,114,000 -1,681,000 -1,430,000 -2,442,000 -3,633,000 -7,584,000 -6,262,000 -5,830,000 -5,023,000 -8,701,000 -4,682,000 -7,611,000        
      investing activities
    		                                            
      acquisition of c2i, net of cash acquired
    		   0 0 0 5,012,000                                      
      purchase of short-term investments
    		0 -49,999,000 -49,999,000     0 0 0 -19,700,000 -24,547,000 0                                
      proceeds from maturity of short-term investments
    		51,055,000       0 0 0 5,000,000 -15,000 10,521,000                                
      purchases of property, plant and equipment
    		-2,792,000 -1,286,000 -1,819,000 -4,141,000 -2,242,000 -2,770,000 -2,134,000 -2,497,000 -2,802,000 -3,669,000 -993,000                                  
      net cash from investing activities
    		48,263,000 -224,000 -51,818,000 -54,141,000 -2,242,000 -2,770,000 2,878,000 -2,497,000 -2,802,000 -3,669,000 24,080,000 -26,434,000 8,807,000 -9,307,000 -2,453,000 385,000 -165,457,000 1,473,000 -575,607,000 -888,000 -1,635,000 -649,000 -665,000 -41,100,000 -226,000 -658,000 -749,000 -454,000 -659,000 -534,000 -227,000 -300,000 -607,000 -113,000 -175,000 -450,000 -173,000        
      financing activities
    		                                            
      payment of taxes on vested restricted stock units
    		-2,814,000 -2,380,000 -9,451,000 -3,274,000 -2,180,000 -1,303,000 -3,832,000 -1,127,000 -2,446,000 -891,000 -2,277,000 -528,000 -774,000 -418,000 -1,447,000 -722,000 -823,000 -710,000 -6,774,000 -684,000 -483,000 -374,000 -2,304,000                      
      proceeds from the exercise of common stock options and employee stock purchases
    		5,791,000 1,814,000 2,967,000 3,264,000 12,469,000 1,292,000 2,968,000 1,772,000 2,556,000 1,288,000 3,962,000 1,808,000 2,257,000 340,000 3,537,000 895,000 4,038,000 2,630,000 3,965,000 3,595,000 4,265,000 3,764,000 2,085,000 3,044,000 4,874,000 2,548,000 4,181,000 1,905,000 1,564,000 312,000 569,000 923,000 511,000 49,000 414,000 253,000 317,000 13,000 633,000      
      net cash from financing activities
    		2,977,000 -566,000 -6,484,000 -4,510,000 10,289,000 -11,000 -864,000 645,000 110,000 397,000 1,685,000 93,000 1,486,000 -75,000 1,990,000 173,000 3,215,000 1,920,000 591,012,000 2,911,000 197,513,000 3,390,000 -219,000 2,965,000 4,797,000 127,919,000 -8,394,000 1,829,000 56,530,000 239,000 901,000 -1,188,000 442,000 -20,000 548,000 32,202,000 317,000 -135,000 19,945,000 -4,000 37,657,000 92,000   
      increase in cash, cash equivalents and restricted cash
    		95,997,000   -34,127,000 38,010,000 26,794,000 -6,952,000 13,700,000 11,479,000 13,399,000 23,593,000     9,004,000                             
      effect of foreign currency on cash, cash equivalents and restricted cash
    		60,000 573,000 74,000 -401,000 146,000 -61,000 -108,000 297,000 -177,000 -7,000 50,000 732,000 -654,000 -423,000 -247,000 164,000 119,000                            
      net increase in cash, cash equivalents and restricted cash
    		96,057,000   -34,528,000 38,156,000 26,733,000 -7,060,000 13,997,000 11,302,000 13,392,000 23,643,000     9,168,000    4,284,000 197,630,000   -36,345,000 3,015,000   149,000                 
      cash, cash equivalents and restricted cash at beginning of period
    		0 0 240,631,000  0 0 217,330,000  0 0 154,996,000  0 0 173,946,000  0 0 349,967,000  0 0 159,920,000  0 0 78,598,000  0 0 34,494,000              
      cash, cash equivalents and restricted cash at end of period
    		96,057,000 33,388,000 187,765,000  38,156,000 26,733,000 210,270,000  11,302,000 13,392,000 178,639,000  16,665,000 -10,168,000 164,364,000  -163,516,000 3,483,000 324,811,000  197,630,000 -5,682,000 153,735,000  3,015,000 124,806,000 68,444,000  54,088,000 -3,394,000 27,755,000              
      supplementary cash flow information:
    		                                            
      purchases of property, plant and equipment included in accounts payable and accrued liability
    		323,000 -472,000 977,000  -1,339,000 137,000 1,754,000  314,000 -1,514,000 1,624,000                                  
      cash paid for tax
    		835,000 1,432,000 121,000 1,031,000 1,188,000   428,000    140,000 366,000                                
      decrease in cash, cash equivalents and restricted cash
    		  -52,940,000          17,319,000 -9,745,000 -9,335,000                              
      net decrease in cash, cash equivalents and restricted cash
    		  -52,866,000          16,665,000 -10,168,000 -9,582,000   3,483,000 -25,156,000    -6,185,000    -10,154,000   -3,394,000 -6,739,000              
      interest on end-of-term debt obligation
    		           0 54,000 54,000 53,000 55,000 54,000 54,000 53,000 54,000 55,000 53,000 54,000  54,000 56,000 64,000  81,000 79,000 70,000              
      operating lease liability
    		               -84,000 -693,000 -644,000 -373,000 -367,000 -358,000 -351,000 -331,000                      
      proceeds from sale of short-term investments
    		       0 0 0 39,773,000                                  
      payment of contingent consideration for acquisition
    		                                            
      payment of long-term debt
    		           -1,187,000 3,000 3,000 -100,000     0    0 0 -12,400,000 -12,500,000         0 0        
      cash, cash equivalents and restricted cash at beginning of year
    		                                            
      cash, cash equivalents and restricted cash at end of year
    		                                            
      supplementary cash flow information of non-cash investing and financing activities:
    		                                            
      purchases of property and equipment included in accounts payable and accrued liabilities
    		                          95,000 250,000   56,000 -146,000      -381,000 423,000      
      cash paid for interest on debt
    		                                            
      loss on disposal of property and equipment
    		           134,000                        0 0        
      acquisition of decipher biosciences, net of cash acquired
    		               0                             
      acquisition of haliodx, net of cash acquired
    		               1,226,000                             
      proceeds from sale of equity securities
    		               0 0                            
      proceeds from issuance of common stock in a public offering, net of issuance costs
    		                                            
      shares issued for purchase consideration for a business combination
    		                                            
      benefit from income taxes
    		           403,000 -152,000 -115,000 -3,000 -961,000 -1,350,000 -152,000 -3,795,000                          
      write-down of excess supplies
    		                   0 0 0 1,088,000                      
      purchase of equity securities
    		                   0                         
      purchases of property and equipment
    		           -1,872,000 -1,714,000 -2,510,000 -2,453,000 -841,000 -1,812,000 -1,527,000 -1,196,000 -888,000 -635,000 -649,000 -665,000 -1,100,000 -232,000 -659,000 -765,000 -454,000 -659,000 -534,000 -227,000 -300,000 -727,000 -113,000 -615,000 -450,000 -173,000        
      impairment of intangible assets
    		            0                                
      proceeds from the issuance of common stock in a public offering, net of issuance costs
    		                0 0 593,821,000                          
      purchases of property and equipment included in accounts payable and accrued liability
    		            -54,000 -273,000 342,000  -988,000 662,000 357,000    113,000                      
      interest paid on debt
    		                0    0 2,000 1,000  11,000 91,000 228,000  494,000 385,000 356,000              
      issuance of common stock for acquisition of haliodx
    		                                            
      gain on disposal of property and equipment
    		                        -6,000 -1,000 -16,000                  
      amortization and write-off of debt discount and issuance costs
    		                               393,000 26,000 27,000 26,000  27,000 27,000 92,000      
      supplies
    		               -1,468,000 379,000 -365,000 -10,000 -201,000 2,585,000 -947,000 -376,000 -198,000 -1,504,000 -1,336,000 -366,000 61,000                 
      acquisition of nanostring diagnostics platform
    		                                            
      proceeds from the sale of property and equipment
    		                                            
      payment of financial lease liability
    		                                            
      deferred purchase consideration for a business combination
    		                                            
      acquisition of business, net of cash acquired
    		                 0 -574,411,000                          
      other income
    		                           0 0 0 -93,000              
      accrued liabilities, deferred revenue and deferred rent
    		                                            
      cash paid for acquisition
    		                                            
      proceeds from legal settlement regarding short-swing profits
    		                           0 0 0 403,000              
      amortization of debt issuance costs
    		                        0 75,000 8,000  8,000 8,000 8,000              
      accrued liabilities
    		                    1,043,000 -693,000 -3,650,000                      
      proceeds from disposal of property and equipment
    		                        6,000 1,000 16,000                  
      proceeds from the issuance of common stock in a public offering
    		                                            
      payment of finance lease liability
    		                        -77,000 -77,000 -75,000                  
      (gain) loss on disposal of property and equipment
    		                                            
      interest on end-of-term debt obligation and prepayment penalty
    		                                            
      right-of-use assets - operating lease and operating lease liability
    		                       -100,000 102,000 -93,000 -80,000                  
      accrued liabilities and deferred rent
    		                       3,970,000 -61,000 1,032,000 287,000 -110,000 767,000 -161,000 228,000 38,000 -429,000 1,551,000 -2,323,000 1,542,000 -1,803,000        
      proceeds from the issuance of long-term debt, net of debt issuance costs
    		                                   0 0 -148,000 24,600,000      
      payment of end-of-term debt obligation and prepayment penalty
    		                                   0 0        
      operating lease liability arising from obtaining right-of-use assets - operating lease at beginning of period
    		                       0                     
      cash and cash equivalents
    		                                            
      restricted cash
    		                                            
      total cash, cash equivalents and restricted cash
    		                                            
      proceeds from the issuance of common stock in a public offering, net of costs
    		                        0        0 0 200,000          
      operating lease liability arising from obtaining right-of-use assets - operating lease
    		                         0 14,118,000                  
      purchases of property and equipment included in accounts payable
    		                                            
      bad debt expense
    		                                   0 0 2,000 66,000 26,000 32,000 22,000 11,000 28,000 
      genzyme co-promotion fee amortization
    		                                   0 -227,000        
      conversion of accrued interest to long-term debt
    		                                   0 193,000        
      payment of capital lease liability
    		                           -75,000 -73,000 -73,000 -71,000 -70,000 -69,000 -69,000 -66,000          
      net receivable for reimbursement of public offering issuance costs
    		                                            
      prepaid expenses and current other assets
    		                            -37,000 337,000 -239,000 -247,000 215,000 269,000 -244,000 -452,000 -10,000      -370,000 463,000 
      proceeds from sale of property and equipment
    		                                0 0 440,000          
      supplies inventory
    		                             1,508,000 767,000 -1,564,000 -443,000 126,000 32,000 -59,000 86,000 150,000 115,000      
      change in restricted cash
    		                               0    0 0     70,000   
      proceeds from issuance of common stock in a private placement, net of issuance costs
    		                                            
      payment of deferred stock offering costs
    		                                            
      net increase in cash and cash equivalents
    		                                  -7,713,000 27,520,000 -7,294,000 -8,463,000 8,372,000 -4,929,000     
      cash and cash equivalents at beginning of year
    		                                            
      cash and cash equivalents at end of year
    		                                            
      conversion of accrued interest on long-term debt
    		                                            
      interest on debt balloon payment and prepayment penalty
    		                                   0 0 0 206,000      
      net decrease in cash and cash equivalents
    		                                -5,268,000            
      cash and cash equivalents at beginning of period
    		                                0 0 59,219,000 0 0 0 39,084,000 0 0 35,014,000 0 71,220,000 
      cash and cash equivalents at end of period
    		                                -5,268,000 -5,043,000 51,506,000 27,520,000 -7,294,000 -8,463,000 47,456,000 -4,929,000 25,247,000 25,798,000 -6,239,000 64,237,000 
      unpaid deferred stock offering
    		                                            
      amortization of debt discount and issuance costs
    		                                       11,000 12,000 11,000 28,000 26,000 
      cash remitted for acquisition, net of cash received
    		                                            
      commissions and issuance costs relating to initial public offering
    		                                            
      fair value of common stock issued for acquisition
    		                                            
      non-cash issuance of long-term debt
    		                                            
      non-cash repayment of long-term debt
    		                                            
      issuance of common stock from the non-cash exercise of common stock warrants
    		                                            
      proceeds from the issuance of common stock in a private placement, net of costs
    		                                            
      unpaid deferred debt issuance costs
    		                                      148,000      
      interest on debt balloon payment
    		                                       20,000 20,000 19,000 20,000 20,000 
      proceeds from issuance of common stock in a private placement, net of costs
    		                                       0     
      commissions and issuance costs relating to the initial public offering
    		                                            
      proceeds from the exercise of common stock options
    		                                       193,000 399,000 92,000 448,000 27,000 
      unpaid deferred stock offering costs
    		                                            
      change in value of preferred stock liability
    		                                            
      proceeds from issuance of long-term debt, net of debt issuance costs
    		                                            
      proceeds from issuance of redeemable convertible preferred stock, net of issuance costs
    		                                            
      payment of convertible preferred stock issuance costs
    		                                            
      equity-based compensation
    		                                            
      change in value of preferred stock warrant liability
    		                                            
      accounts receivables
    		                                            
      deferred genzyme co-promotion fee
    		                                            
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.